SEC Form 4 · accession 0001179110-18-012296
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alejandra Carvajal
Officer — Chief Legal Officer
Period of report
Oct 17, 2018
Accepted (ET)
Oct 19, 2018 · 6:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Oct 17, 2018 | A | 39,000 | A | — | — | Common Stock | 39,000 | 39,000 | D |
Explanation of responses
- F1Each Restricted Stock Unit represents a contingent right to receive one share of MNTA common stock.
- F2Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years.